Olema Oncology to Participate in Upcoming Investor Conferences
Globe Newswire•16/11/2026•16:30 ET
0
Key Highlights
- ➤Olema to participate in three upcoming healthcare investor conferences
- ➤Fireside chats scheduled November 30 through December 2, 2026
- ➤Palazestrant currently advancing in two Phase 3 clinical trials
- ➤OP-3136 currently in a Phase 1 clinical study
Expert Statements
Courtney O’Konek, Vice President, Corporate Communications at Olema Oncology
“Olema Oncology”
SAN FRANCISCO, Nov. 16, 2026 (GLOBE NEWSWIRE) -- Olema Oncology, Inc. (“Olema,” Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for breast cancer and beyond, today announced that the Company will participate in the following upcoming investor conferences:
9(th) Annual Evercore Healthcare Conference Date and Time: November 30, 2026 at 2:35 p.m. ET Format: Fireside Chat Location: Miami, FL
Get started
Create a free account to read the full story.
